Chain Drug Review - Aciphex approved
The first seven-day treatment of H. pylori infection has been approved by the Food and Drug Administration. Aciphex, a proton pump inhibitor, is being copromoted by Eisai Go. (its Japanese-based developer) and Janssen Pharmaceutica Inc. (a unit of Johnson & Johnson). H. pylori, a type of stomach bacteria, is the most common cause of peptic ulcers.
Related Results
n AciphexAciphexAciphex approvalEisai, Janssen Revamp Aciphex PackagingTeva Provides Update on Generic Aciphex Litigation
COPYRIGHT 2002 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
